Feedback / Questions
astegolimab (RG 6149) - Amgen, Roche
Astegolimab: NME submission in US for COPD in 2025
(Roche)
-
Apr 23, 2024 -
Q1 2024 Results: Regulatory submission in EU for COPD in 2025
BLA • European regulatory
•
Chronic Obstructive Pulmonary Disease • Immunology
https://assets.roche.com/f/176343/x/14b2fa29c8/irp240424.pdf
Apr 23, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious